Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Payment to doctors

- PMLiVE

Grail to initiate largest ever UK cancer screening study

Will start testing on 50,000 people in early 2019

- PMLiVE

NICE U-turn sees Opdivo backed as adjuvant therapy for skin cancer

But it is only available via the CDF for now

- PMLiVE

Abbott’s wearable glucose monitor to be available across England

FreeStyle Libre will be prescribed to those with T1 diabetes

- PMLiVE

Medical AI gets £50m boost and five new centres in UK

Medical imaging and pathology to undergo AI revolution

- PMLiVE

Healthcare prevention plan worthy, but funding an issue

Aims to boost national life expectancy by five years

- PMLiVE

Warning ‘at red’ on no deal Brexit medicines chaos

Report says it's already too late to prepare for a no deal scenario

- PMLiVE

Budget 2018: UK life sciences sector delivers its verdict

UK Chancellor Philip Hammond delivered a budget that was broadly pro-business but contained mixed news for the life sciences industry, according to two industry bodies.The headline news of an additional...

- PMLiVE

In conversation with Pfizer’s Erik Nordkamp

Pfizer’s UK managing director and newly appointed ABPI President talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe

Pharma: in search of the sustainable ‘win win’ with the NHS

Fiona Bride on how Novartis is responding to new models of care

- PMLiVE

Hancock’s ‘Tech Revolution’ for NHS to be limited by budgets

Vision for a tech-driven NHS unveiled, but is there money to fund it?

- PMLiVE

Hancock says UK genome service is now ‘rolling out’

Health secretary also announces a £240m social care boost

- PMLiVE

UK pharma to work with innovation network on NHS uptake

The five year deal covers AI, genomics, personalised medicine and more

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links